Meanwhile, subgroup analysis of the pathological stage of tumors in the TCGA-BLCA cohort revealed that the levels of GNG4 expression increased gradually from stage I to stage IV (Figure 4F). The gene discussed is GNG4; the disease is bladder transitional cell carcinoma.